In the RADAR trial high-risk arm, what criteria were used to define patients as high-risk and eligible for the isatuximab-containing regimen?
Presence of any single high-risk cytogenetic feature
Two or more high-risk features as defined by IMWG 2020
Only patients with del(17p) or t(4;14)